A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)

Summary

This is a randomized, placebo-controlled, double-blind, multi-site study in which up to approximately 36 subjects with a recent C. difficile infection (CDI) who have completed a standard of care course of CDI antibiotics and have achieved clinical cure based on signs and symptoms, will be randomized to 7 or 28 daily doses of ART24 or placebo. Subjects will be followed for 6 months after the last dose of study drug.

Timeline

Start

2020-02-27

Primary completion

2022-07-07

Completion

2022-10-13

Drugs

Indications